Mastering Current Management of CLL

Download All
Learn how hematology-oncology pharmacists can optimize outcomes for patients with CLL with an expert commentary plus on-demand Webcast and downloadable slides from a live CCO Webinar.
Emily Bucholtz Headshot
Emily Bucholtz, RPh

ClinicalThought

How do you talk to patients with CLL about managing their disease with BTK inhibitors? Read my thoughts on how I use my interactions to educate patients about treatment options, planning for AEs, and improve outcomes.

Emily Bucholtz Headshot Emily Bucholtz, RPh Released: April 29, 2021
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AbbVie
AstraZeneca
Pharmacyclics LLC, An AbbVie Company
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue